Viewing Study NCT01714661

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:21 PM
Ignite Modification Date: 2026-06-08 @ 10:19 AM
Study NCT ID: NCT01714661
Status: COMPLETED
Last Update Posted: 2016-05-03
First Post: 2012-10-19
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy
Sponsor: FORUM Pharmaceuticals Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Schizophrenia View
None Impaired Cognition View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Schizophrenia View
None Cognition View
None Cognition Impairment View
None Alpha-7 nAChR View